These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31749602)

  • 21. Evaluation of the Repeatability of the LacryDiag Ocular Surface Analyzer for Assessment of the Meibomian Glands and Tear Film.
    Ward CD; Murchison CE; Petroll WM; Robertson DM
    Transl Vis Sci Technol; 2021 Aug; 10(9):1. PubMed ID: 34338722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular surface predisposing factors for digital display-induced dry eye.
    Talens-Estarelles C; García-Marqués JV; Cerviño A; García-Lázaro S
    Clin Exp Optom; 2023 May; 106(4):373-379. PubMed ID: 35254958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agreement of noninvasive tear break-up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M.
    Lee R; Yeo S; Aung HT; Tong L
    Clin Ophthalmol; 2016; 10():1785-1790. PubMed ID: 27695283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of ocular redness measurements obtained with keratograph 5M and correlation with subjective grading scales.
    Pérez-Bartolomé F; Sanz-Pozo C; Martínez-de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
    J Fr Ophtalmol; 2018 Nov; 41(9):836-846. PubMed ID: 30293826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Tear Function Outcomes following Collagen Cross-Linking Treatment in Ectatic Corneas.
    Wang X; Bai X; Jin C; Zhao L; Wei R
    J Ophthalmol; 2022; 2022():1910607. PubMed ID: 35321348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Prosthetic Replacement of the Ocular Surface Ecosystem Anterior Surface Condition Using Noninvasive Keratograph Break-Up Time.
    Nodecker K; Madabhushi S; Brocks D
    Eye Contact Lens; 2024 Jan; 50(1):52-55. PubMed ID: 37882741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tear Film Surface Quality in Modern Daily Disposable Contact Lens Wear.
    Mousavi M; Garaszczuk IK; De Jesus DA; Szczesna-Iskander DH; Armstrong RA; Nichols KK; Iskander DR
    Eye Contact Lens; 2021 Dec; 47(12):631-637. PubMed ID: 34797270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Vitreoretinal Surgery on Ocular Surface Dynamics Using Keratograph 5M.
    Hwang GE; Lee ES; Kim HD
    Korean J Ophthalmol; 2023 Oct; 37(5):417-428. PubMed ID: 37670615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Dry Eye Disease Among Individuals Scheduled for Cataract Surgery in a Norwegian Cataract Clinic.
    Graae Jensen P; Gundersen M; Nilsen C; Gundersen KG; Potvin R; Gazerani P; Chen X; Utheim TP; Utheim ØA
    Clin Ophthalmol; 2023; 17():1233-1243. PubMed ID: 37138823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and morphological evaluation of the meibomian glands and ocular surface assessment at high altitude.
    Li Z; Wan W; Ji Y; Zheng S; Hu K
    Indian J Ophthalmol; 2023 Apr; 71(4):1483-1487. PubMed ID: 37026287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial Sessions of a Novel Low-Level Light Therapy Device for Home Treatment of Dry Eye Disease.
    Giannaccare G; Vaccaro S; Pellegrini M; Borselli M; Carnovale Scalzo G; Taloni A; Pietropaolo R; Odadi AS; Carnevali A
    Ophthalmol Ther; 2023 Feb; 12(1):459-468. PubMed ID: 36484948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive screening of ocular surface disease in otherwise healthy patients scheduled for cataract surgery.
    Giannaccare G; Borselli M; Rossi C; Carnovale Scalzo G; Pellegrini M; Vaccaro S; Scalia G; Lionetti G; Mancini A; Bianchi P; Scorcia V
    Eur J Ophthalmol; 2024 Jan; ():11206721241228621. PubMed ID: 38291650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of the addition of oral administration of curcumin-phospholipid to hyaluronic acid-based tear substitute for the treatment of dry eye disease.
    Borselli M; Ferrari FF; Bianchi P; Rossi C; Scalzo GC; Mangialavori D; Scorcia V; Giannaccare G
    Front Ophthalmol (Lausanne); 2023; 3():1236525. PubMed ID: 38983042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.
    Portela RC; Fares NT; Machado LF; São Leão AF; de Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    J Glaucoma; 2018 Sep; 27(9):794-801. PubMed ID: 29916999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multimodal evaluation of the ocular surface using a the new Lacrydiag device].
    Remongin PE; Rousseau A; Best AL; Ben Hadj Salah W; Legrand M; Benichou J; Barreau E; Labetoulle M
    J Fr Ophtalmol; 2021 Mar; 44(3):313-320. PubMed ID: 33583607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Ocular Surface Damage during the Course of Type 2 Diabetes Mellitus.
    He F; Zhao Z; Liu Y; Lu L; Fu Y
    J Ophthalmol; 2018; 2018():1206808. PubMed ID: 30116624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location and pattern of non-invasive keratographic tear film break-up according to dry eye disease subtypes.
    Kim J; Kim JY; Seo KY; Kim TI; Chin HS; Jung JW
    Acta Ophthalmol; 2019 Dec; 97(8):e1089-e1097. PubMed ID: 31062499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
    Zhao S; Le Q
    BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability, repeatability, and accordance between three different corneal diagnostic imaging devices for evaluating the ocular surface.
    Garcia-Terraza AL; Jimenez-Collado D; Sanchez-Sanoja F; Arteaga-Rivera JY; Morales Flores N; Pérez-Solórzano S; Garfias Y; Graue-Hernández EO; Navas A
    Front Med (Lausanne); 2022; 9():893688. PubMed ID: 35966863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cell therapy in aqueous deficient dry eye disease.
    Møller-Hansen M
    Acta Ophthalmol; 2023 Oct; 101 Suppl 277():3-27. PubMed ID: 37840443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.